Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anesthetics, Local | 5 | 2024 | 80 | 2.080 |
Why?
|
| Operating Tables | 2 | 2023 | 2 | 1.430 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2023 | 14 | 0.870 |
Why?
|
| Nerve Block | 1 | 2024 | 67 | 0.860 |
Why?
|
| Antiemetics | 1 | 2023 | 23 | 0.860 |
Why?
|
| Embolism, Amniotic Fluid | 2 | 2018 | 31 | 0.730 |
Why?
|
| Internship and Residency | 3 | 2018 | 1161 | 0.700 |
Why?
|
| Complement C1 Inhibitor Protein | 1 | 2018 | 8 | 0.630 |
Why?
|
| Celiac Plexus | 1 | 2017 | 4 | 0.580 |
Why?
|
| Autonomic Nerve Block | 1 | 2017 | 4 | 0.580 |
Why?
|
| Ganglia, Sympathetic | 2 | 2007 | 23 | 0.530 |
Why?
|
| Herpes Zoster | 3 | 2008 | 23 | 0.520 |
Why?
|
| Ethanol | 1 | 2017 | 161 | 0.520 |
Why?
|
| Pulmonary Embolism | 1 | 2017 | 174 | 0.480 |
Why?
|
| Fat Emulsions, Intravenous | 2 | 2012 | 72 | 0.470 |
Why?
|
| Obesity, Morbid | 1 | 2016 | 186 | 0.440 |
Why?
|
| Vitamin K | 1 | 2012 | 35 | 0.400 |
Why?
|
| Organizational Policy | 1 | 2012 | 54 | 0.400 |
Why?
|
| Anesthesia, Local | 2 | 2011 | 48 | 0.400 |
Why?
|
| Benzodiazepines | 1 | 2012 | 101 | 0.390 |
Why?
|
| Optic Neuropathy, Ischemic | 2 | 2009 | 44 | 0.380 |
Why?
|
| Warfarin | 1 | 2012 | 118 | 0.380 |
Why?
|
| Workload | 1 | 2012 | 147 | 0.370 |
Why?
|
| Postoperative Complications | 3 | 2017 | 3020 | 0.370 |
Why?
|
| Parenteral Nutrition | 1 | 2012 | 187 | 0.370 |
Why?
|
| Anesthesiology | 1 | 2012 | 94 | 0.370 |
Why?
|
| Social Media | 1 | 2012 | 108 | 0.350 |
Why?
|
| Clinical Competence | 2 | 2018 | 972 | 0.350 |
Why?
|
| Analgesia, Epidural | 2 | 2010 | 27 | 0.330 |
Why?
|
| Perioperative Care | 2 | 2008 | 195 | 0.320 |
Why?
|
| Lipectomy | 1 | 2008 | 8 | 0.320 |
Why?
|
| Antipsychotic Agents | 1 | 2012 | 373 | 0.310 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2008 | 52 | 0.310 |
Why?
|
| Bupivacaine | 2 | 2005 | 21 | 0.310 |
Why?
|
| Steroids | 2 | 2008 | 203 | 0.300 |
Why?
|
| Patient Safety | 1 | 2012 | 397 | 0.290 |
Why?
|
| Anticoagulants | 1 | 2012 | 580 | 0.290 |
Why?
|
| Humans | 26 | 2024 | 123265 | 0.280 |
Why?
|
| Isoflurane | 1 | 2007 | 45 | 0.280 |
Why?
|
| Injections, Spinal | 1 | 2007 | 118 | 0.280 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2007 | 57 | 0.280 |
Why?
|
| Anesthetics, Inhalation | 1 | 2007 | 46 | 0.280 |
Why?
|
| Coronary Restenosis | 1 | 2006 | 20 | 0.270 |
Why?
|
| Hiccup | 1 | 2005 | 6 | 0.250 |
Why?
|
| Ganglionic Blockers | 1 | 2004 | 13 | 0.240 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2006 | 257 | 0.230 |
Why?
|
| Neuralgia | 1 | 2004 | 45 | 0.230 |
Why?
|
| Heart Arrest | 1 | 2008 | 342 | 0.230 |
Why?
|
| Emergency Medical Services | 1 | 2008 | 434 | 0.220 |
Why?
|
| Manikins | 1 | 2024 | 134 | 0.220 |
Why?
|
| Embolism, Air | 1 | 2003 | 25 | 0.210 |
Why?
|
| Respiratory Paralysis | 1 | 2002 | 7 | 0.210 |
Why?
|
| Administration, Intravenous | 1 | 2023 | 143 | 0.210 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2003 | 42 | 0.210 |
Why?
|
| Equipment Failure | 2 | 2016 | 122 | 0.200 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2024 | 311 | 0.180 |
Why?
|
| Stents | 1 | 2006 | 876 | 0.170 |
Why?
|
| Combined Modality Therapy | 1 | 2023 | 1239 | 0.170 |
Why?
|
| Body Weight | 1 | 2023 | 1007 | 0.160 |
Why?
|
| Empathy | 1 | 2018 | 57 | 0.150 |
Why?
|
| Female | 10 | 2023 | 65619 | 0.150 |
Why?
|
| Body Mass Index | 1 | 2023 | 1553 | 0.140 |
Why?
|
| Pain, Intractable | 1 | 2017 | 24 | 0.140 |
Why?
|
| Capillary Permeability | 2 | 2008 | 77 | 0.140 |
Why?
|
| Morphine | 2 | 2008 | 88 | 0.140 |
Why?
|
| Survivors | 1 | 2018 | 344 | 0.130 |
Why?
|
| Sacrococcygeal Region | 2 | 2007 | 32 | 0.130 |
Why?
|
| Fellowships and Scholarships | 1 | 2018 | 270 | 0.130 |
Why?
|
| Accidental Falls | 1 | 2016 | 105 | 0.120 |
Why?
|
| Equipment Design | 2 | 2024 | 604 | 0.110 |
Why?
|
| Lipids | 1 | 2017 | 513 | 0.110 |
Why?
|
| Thrombelastography | 1 | 2014 | 55 | 0.110 |
Why?
|
| Blood Coagulation | 1 | 2014 | 120 | 0.110 |
Why?
|
| Male | 10 | 2023 | 60335 | 0.100 |
Why?
|
| Pain | 2 | 2008 | 470 | 0.100 |
Why?
|
| Mesentery | 2 | 2008 | 28 | 0.090 |
Why?
|
| Data Collection | 1 | 2012 | 383 | 0.090 |
Why?
|
| Amides | 1 | 2010 | 83 | 0.090 |
Why?
|
| Pregnancy | 3 | 2018 | 7129 | 0.090 |
Why?
|
| Anesthetics | 1 | 2011 | 81 | 0.080 |
Why?
|
| Internet | 1 | 2012 | 378 | 0.080 |
Why?
|
| Middle Aged | 4 | 2023 | 26089 | 0.080 |
Why?
|
| Injections, Epidural | 1 | 2008 | 4 | 0.080 |
Why?
|
| Thrombosis | 1 | 2014 | 518 | 0.080 |
Why?
|
| Medication Errors | 1 | 2010 | 184 | 0.080 |
Why?
|
| Denervation | 1 | 2008 | 29 | 0.080 |
Why?
|
| Motor Neurons | 1 | 2008 | 139 | 0.070 |
Why?
|
| Intraoperative Complications | 1 | 2009 | 174 | 0.070 |
Why?
|
| Joints | 1 | 2007 | 23 | 0.070 |
Why?
|
| Guidelines as Topic | 1 | 2008 | 197 | 0.070 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2008 | 160 | 0.070 |
Why?
|
| Ticlopidine | 1 | 2006 | 28 | 0.070 |
Why?
|
| Delayed-Action Preparations | 1 | 2006 | 110 | 0.070 |
Why?
|
| Paclitaxel | 1 | 2006 | 120 | 0.070 |
Why?
|
| Shock, Hemorrhagic | 1 | 2006 | 51 | 0.060 |
Why?
|
| Adult | 5 | 2017 | 29100 | 0.060 |
Why?
|
| Spinal Stenosis | 1 | 2005 | 9 | 0.060 |
Why?
|
| Aspirin | 1 | 2006 | 220 | 0.060 |
Why?
|
| Sirolimus | 1 | 2006 | 220 | 0.060 |
Why?
|
| Leukocytes | 1 | 2006 | 206 | 0.060 |
Why?
|
| Pharynx | 1 | 2024 | 64 | 0.060 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 1078 | 0.060 |
Why?
|
| Masks | 1 | 2024 | 38 | 0.060 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2024 | 91 | 0.060 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 3384 | 0.060 |
Why?
|
| Young Adult | 1 | 2017 | 8867 | 0.050 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2005 | 123 | 0.050 |
Why?
|
| Aged | 5 | 2011 | 19196 | 0.050 |
Why?
|
| Abdominal Muscles | 1 | 2002 | 27 | 0.050 |
Why?
|
| Coronary Vessels | 1 | 2006 | 527 | 0.050 |
Why?
|
| Thorax | 1 | 2002 | 72 | 0.050 |
Why?
|
| Reoperation | 1 | 2005 | 819 | 0.050 |
Why?
|
| Carbon Dioxide | 1 | 2003 | 273 | 0.050 |
Why?
|
| Recurrence | 1 | 2005 | 1418 | 0.050 |
Why?
|
| Oxygen | 1 | 2024 | 550 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2005 | 1168 | 0.050 |
Why?
|
| United States | 1 | 2012 | 10654 | 0.040 |
Why?
|
| Venules | 2 | 2008 | 25 | 0.040 |
Why?
|
| Emulsions | 1 | 2017 | 65 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2012 | 13918 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2008 | 4501 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2008 | 1218 | 0.030 |
Why?
|
| Veins | 1 | 2014 | 106 | 0.030 |
Why?
|
| Arteries | 1 | 2014 | 222 | 0.030 |
Why?
|
| Phenylephrine | 1 | 2010 | 37 | 0.020 |
Why?
|
| Lidocaine | 1 | 2010 | 48 | 0.020 |
Why?
|
| Rats | 2 | 2008 | 3666 | 0.020 |
Why?
|
| Swine | 1 | 2014 | 1167 | 0.020 |
Why?
|
| Drug Overdose | 1 | 2010 | 64 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2010 | 137 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2011 | 6392 | 0.020 |
Why?
|
| Blindness | 1 | 2009 | 72 | 0.020 |
Why?
|
| Electromyography | 1 | 2008 | 164 | 0.020 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2010 | 256 | 0.020 |
Why?
|
| Visual Fields | 1 | 2009 | 133 | 0.020 |
Why?
|
| Microcirculation | 1 | 2008 | 93 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2010 | 389 | 0.020 |
Why?
|
| Adenine | 1 | 2008 | 101 | 0.020 |
Why?
|
| Risk Factors | 2 | 2010 | 10035 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2006 | 318 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2009 | 843 | 0.010 |
Why?
|
| Animals | 3 | 2014 | 33859 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2008 | 3046 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2009 | 3239 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2009 | 16069 | 0.010 |
Why?
|